168 related articles for article (PubMed ID: 36806646)
1. Inadequate diagnostic testing and systemic antifungal prescribing for tinea capitis in an observational cohort study of 3.9 million children, United States.
Gold JAW; Benedict K; Dulski TM; Lipner SR
J Am Acad Dermatol; 2023 Jul; 89(1):133-135. PubMed ID: 36806646
[No Abstract] [Full Text] [Related]
2. Systemic antifungal therapy for tinea capitis in children.
Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C
Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520
[TBL] [Abstract][Full Text] [Related]
3. Systemic antifungal therapy for tinea capitis in children.
González U; Seaton T; Bergus G; Jacobson J; Martínez-Monzón C
Cochrane Database Syst Rev; 2007 Oct; (4):CD004685. PubMed ID: 17943825
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole.
Gupta AK; Adam P; Dlova N; Lynde CW; Hofstader S; Morar N; Aboobaker J; Summerbell RC
Pediatr Dermatol; 2001; 18(5):433-8. PubMed ID: 11737692
[TBL] [Abstract][Full Text] [Related]
5. Tinea capitis update: a continuing conflict with an old adversary.
Chen BK; Friedlander SF
Curr Opin Pediatr; 2001 Aug; 13(4):331-5. PubMed ID: 11717558
[TBL] [Abstract][Full Text] [Related]
6. The assessment and management of tinea capitis in children.
Ali S; Graham TA; Forgie SE
Pediatr Emerg Care; 2007 Sep; 23(9):662-5; quiz 666-8. PubMed ID: 17876261
[TBL] [Abstract][Full Text] [Related]
7. A Retrospective Study of Tinea Capitis Management in General Pediatric Clinics and Pediatric Emergency Departments at 2 US Centers.
Woodard AA; Le TK; DiBiagio JR; Goldenberg NA; Cohen BA
J Pediatr; 2021 Jul; 234():269-272. PubMed ID: 33794219
[TBL] [Abstract][Full Text] [Related]
8. New treatments for tinea capitis.
Chan YC; Friedlander SF
Curr Opin Infect Dis; 2004 Apr; 17(2):97-103. PubMed ID: 15021047
[TBL] [Abstract][Full Text] [Related]
9. [Tinea capitis. Therapeutic options in the post-griseofulvin era].
Möhrenschlager M; Korting HC; Seidl HP; Ring J; Abeck D
Hautarzt; 2002 Dec; 53(12):788-94. PubMed ID: 12444518
[TBL] [Abstract][Full Text] [Related]
10. Tinea capitis in children: a systematic review of management.
Gupta AK; Mays RR; Versteeg SG; Piraccini BM; Shear NH; Piguet V; Tosti A; Friedlander SF
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2264-2274. PubMed ID: 29797669
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcomes for tinea capitis in a skin of color population.
Bhanusali D; Coley M; Silverberg JI; Alexis A; Silverberg NB
J Drugs Dermatol; 2012 Jul; 11(7):852-6. PubMed ID: 22777228
[TBL] [Abstract][Full Text] [Related]
12. Tinea capitis: a current perspective.
Elewski BE
J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):1-20; quiz 21-4. PubMed ID: 10607315
[TBL] [Abstract][Full Text] [Related]
13. Tinea capitis: a treatment update.
Roberts BJ; Friedlander SF
Pediatr Ann; 2005 Mar; 34(3):191-200. PubMed ID: 15792111
[TBL] [Abstract][Full Text] [Related]
14. Management of tinea capitis in infants and children in the United States: A national survey of pediatric dermatologists.
Guo L; Tran J; Sun DI; Newton JS; D'Amiano NM; Lai J; Cohen B
Pediatr Dermatol; 2024; 41(2):263-265. PubMed ID: 38342578
[TBL] [Abstract][Full Text] [Related]
15. Oral griseofulvin remains the treatment of choice for tinea capitis in children.
Bennett ML; Fleischer AB; Loveless JW; Feldman SR
Pediatr Dermatol; 2000; 17(4):304-9. PubMed ID: 10990583
[TBL] [Abstract][Full Text] [Related]
16. Exploring treatment and antifungal resistance in an outbreak of tinea caused by Microsporum audouinii.
Johansen CD; Shen JJR; Astvad KMT; Jemec GBE; Christensen JJ; Saunte DML
Mycoses; 2024 Jul; 67(7):e13760. PubMed ID: 38943042
[TBL] [Abstract][Full Text] [Related]
17. Tinea capitis: advances and a needed paradigm shift.
Le TK; Cohen BA
Curr Opin Pediatr; 2021 Aug; 33(4):387-391. PubMed ID: 34226424
[TBL] [Abstract][Full Text] [Related]
18. Tinea capitis: an overview with emphasis on management.
Gupta AK; Hofstader SL; Adam P; Summerbell RC
Pediatr Dermatol; 1999; 16(3):171-89. PubMed ID: 10383772
[TBL] [Abstract][Full Text] [Related]
19. The rising menace of antifungal resistance in dermatophytes among the patients of tinea capitis.
Zeeshan F; Sabir M; Uddin F
J Pak Med Assoc; 2023 Jan; 73(1):43-48. PubMed ID: 36842005
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic options in the treatment of tinea capitis.
Chan YC; Friedlander SF
Expert Opin Pharmacother; 2004 Feb; 5(2):219-27. PubMed ID: 14996619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
